Google Übersetzer
Vivos Therapeutics, Inc.
About
0.68USD+0.03 +5.12%
Closed • Updated at 17:34 GMT+00:00Market Cap$9.45M
Volume180.4K
Beta-0.39
RSI40.56
Gross Margin53.70%
Vivos Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 20 2026
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
Apr 15 2026
Vivos Therapeutics Reports Full Year 2025 Financial Results
Apr 15 2026
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
Apr 7 2026
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
Mar 26 2026
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
Recent Videos
Vivos Therapeutics (VVOS) Bizumentary
May 08, 2026
Kirk Huntsman, CEO of Vivos Therapeutics | The Big Biz Show
Apr 23, 2026
Vivos Therapeutics Q4 2025 Earnings Call | Revenue Surges on FDA-Cleared Sleep Apnea Device Adoption
Apr 16, 2026
97% Success Rate: Revolutionary Dental Device Changes Lives! #shorts
Apr 16, 2026
Community Chat
Ask AI
Try asking
